Ralliant Corporation (RAL) To Go Ex-Dividend on June 8th

Ralliant Corporation (NYSE:RAL) declared a quarterly dividend on Thursday, May 7th. Investors of record on Monday, June 8th will be paid a dividend of 0.05 per share on Tuesday, June 23rd. This represents a c) annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, June 8th.

Ralliant Trading Up 2.9%

Shares of Ralliant stock opened at $47.21 on Friday. The firm has a 50-day simple moving average of $44.26 and a two-hundred day simple moving average of $47.00. The company has a market cap of $5.28 billion and a P/E ratio of 24.09. Ralliant has a fifty-two week low of $37.27 and a fifty-two week high of $57.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. The company’s quarterly revenue was up 1.2% compared to the same quarter last year. As a group, equities analysts predict that Ralliant will post 2.37 earnings per share for the current fiscal year.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.